Northwire Canada EditionSaturday, July 18, 2026
Sign inSubscribe
Northwire
⌕
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%

Healthcare

Page 110
  1. Nov 03, 2025 · 07:45 · VVTM

    /R E P E A T -- VVT Med Receives Order from Major US Healthcare Network NorthWell Health and Enters Into Investor Relations Agreements/

    /R E P E A T -- VVT Med Receives Order from Major US Healthcare Network NorthWell Health and Enters Into Investor Relations Agreements/

    01
  2. Nov 03, 2025 · 07:03 · TLT

    Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug

    Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug

    02
  3. Oct 31, 2025 · 20:35 · ONCO

    Onco-Innovations sets out updates from the past months

    Onco-Innovations sets out updates from the past months

    03
  4. Oct 31, 2025 · 19:51 · QNTM

    Quantum BioPharma Ltd. Provides Corporate Update

    Quantum BioPharma Ltd. Provides Corporate Update

    04
  5. Oct 31, 2025 · 19:24 · GUD

    Knight Therapeutics closes revolving credit facility

    Knight Therapeutics closes revolving credit facility

    05
  6. Oct 31, 2025 · 19:00 · HELP

    Cybin closes $175-million (U.S.) offering

    Cybin closes $175-million (U.S.) offering

    06
  7. Oct 31, 2025 · 18:00 · ONCO

    Onco-Innovations Provides Shareholder Update Following Cboe Canada Investor Spotlight

    Onco-Innovations Provides Shareholder Update Following Cboe Canada Investor Spotlight

    07
  8. Oct 31, 2025 · 17:15 · GUD

    Knight Announces Closing of US$100 Million Revolving Credit Facility

    Knight Announces Closing of US$100 Million Revolving Credit Facility

    08
  9. Oct 31, 2025 · 17:13 · WELL

    Well Health's Wellstar arranges $62M Series B financing

    Well Health's Wellstar arranges $62M Series B financing

    09
  10. Oct 31, 2025 · 16:26 · PHRX

    Pharmadrug arranges $445,686 debt restructuring

    Pharmadrug arranges $445,686 debt restructuring

    10
  11. Oct 31, 2025 · 15:52 · PTEC

    Principal signs R&D deal with University of Oxford

    Principal signs R&D deal with University of Oxford

    11
  12. Oct 31, 2025 · 08:15 · WELL

    WELL Subsidiary WELLSTAR Technologies Announces $62M Financing to Support Its Pre-Spinout Growth Strategy

    WELL Subsidiary WELLSTAR Technologies Announces $62M Financing to Support Its Pre-Spinout Growth Strategy

    12
  13. Oct 31, 2025 · 07:30 · PTEC

    PRINCIPAL TECHNOLOGIES ENTERS R&D AGREEMENT WITH OXFORD AND DIVESTS OF MAJORITY OWNERSHIP OF E&E CRO CONSULTING

    PRINCIPAL TECHNOLOGIES ENTERS R&D AGREEMENT WITH OXFORD AND DIVESTS OF MAJORITY OWNERSHIP OF E&E CRO CONSULTING

    13
  14. Oct 31, 2025 · 02:36 · 4565

    Nxera Pharma Receives a Manufacturing Approval Partial Amendment Regarding the Addition of a Manufacturing Site in Asia for QUVIVIQ(TM) 25 and 50 mg

    Nxera Pharma Receives a Manufacturing Approval Partial Amendment Regarding the Addition of a Manufacturing Site in Asia for QUVIVIQ(TM) 25 and 50 mg

    14
← Newer Older →